Incretin effect: GLP-1, GIP, DPP4.

@article{Kazafeos2011IncretinEG,
  title={Incretin effect: GLP-1, GIP, DPP4.},
  author={Kyriafeos Kazafeos},
  journal={Diabetes research and clinical practice},
  year={2011},
  volume={93 Suppl 1},
  pages={S32-6}
}
The term incretin effect was used to describe the fact that oral glucose load produces a greater insulin response than that of an isoglycemic intravenous glucose infusion. This difference has been attributed to gastrointestinal peptides GLP-1 and GIP. Since incretin effect is reduced in subjects with type 2 diabetes, despite GLP-1 activity preservation, two forms of incretin-based treatment have emerged: GLP-1R agonists, administered subcutaneously and DPP-4 inhibitors, administered orally… CONTINUE READING
27 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…